
Attendees
Previous GDDIF Attendees Include:
AB Science
Almirall, S.A
Amgen
Angelini
Arvinas
Astex Pharmaceuticals
AstraZeneca
Bayer
Bicycle Therapeutics
Boehringer Ingelheim
Bristol Myers Squibb
Byondis
Carbon Logic Biotech
Centogene
Centre for Drug Design and Discovery (CD3)
Charles River Laboratories
Charm Therapeutics
Confo Therapeutics
Crescendo Biologics
Eisai
EMBL-EBI
Evox Therapeutics
Fierce Unicorn
Fisher Friedman IP Group
Freie Universitat Berlin
Galapagos NV
Genmab
Genome Biologics
Gilead Sciences
GlaxoSmithKline
Goethe-Universitat Hospital
Heath Innovation Research Alliance Northern Ireland
Hubrecht Organoid Technology
IRCCS San Raffaele
Janssen (Johnson & Johnson)
Laudea Research GmbH
Leibniz Institute for Farm Animal Biology
Leibniz Institute for Molecular Pharmacology (FMP)
Leiden University
LEO Pharma
Lhasa Limited
Lonza
Lygature
Max Delbruck Center
Max Planck Institute
Medibiofarma S.L.
Merck Group
Merck Sharp & Dohme (MSD)
Neurocrine Biosciences
Novartis
Parkinson's UK
Pfizer
Pharmablock
Radboud University Nijmegen
Roche
Sosei Heptares
Storm Therapeutics
Symeres
Technische Universitat Berlin
Tehran Polytechnic
TroplQ Health Sciences
Univercity Medicine Berlin
University of Groningen
University of Jerusalem
Vertex Pharmaceuticals
Medicinal Chemistry
CRO
CDMO
Research and Development,
Quantum Computing
New Drug Modalities
Collaborations / Business Development
Therapeutic Discovery
Advanced Therapies
Antibody Discovery
Biomarker Discovery
Screening ML / AI / LLM / Quantum / Digital
Biologics
R&D
Solution Architecture
Patient Engagement
Clinical Operations / Trials
Outsourcing
Digital Convergence
LLM, ELM, ML, AI
Data Management
Clinical Data
Computational Chemistry
Information Technology
Drug Design Cheminformatics
Bioinformatics
Automation
CEO
CTO
CSO
CMO
Director
Vice President
Divisional Heads
Managers
Executives
ETC